Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 19/20 | 0.75 |
| ▸ | BCL2L1 | Q07817 | 3/20 | 0.68 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.68 |
| ▸ | BCL2L2 | Q92843 | 2/20 | 0.68 |
| ▸ | NSD2 | O96028 | 1/20 | 0.68 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.68 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.68 |
| ▸ | BID | P55957 | 1/20 | 0.68 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.68 |
| ▸ | ASPH | Q12797 | 1/20 | 0.68 |
| ▸ | BAD | Q92934 | 1/20 | 0.68 |
| ▸ | NSD1 | Q96L73 | 1/20 | 0.68 |
| ▸ | NSD3 | Q9BZ95 | 1/20 | 0.68 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19853638 | 0.95 | BCL2 (0.83) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL21573177 | 0.95 | BCL2 (0.76) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL21573179 | 0.94 | BCL2 (0.78) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL21573191 | 0.94 | BCL2 (0.75) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL21573204 | 0.94 | BCL2 (0.76) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL22562895 | 0.92 | BCL2 (0.83) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL19853741 | 0.92 | BCL2 (0.82) | BCL2 | |
| SCHEMBL24982714 | 0.91 | BCL2 (0.75) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL20580480 | 0.91 | BCL2 (0.90) | BCL2BCL2L1MCL1BCL2L2NSD2 | |
| SCHEMBL29376240 | 0.91 | BCL2 (0.90) | BCL2BCL2L1MCL1BCL2L2NSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3672594-B1 | COMBINATION PRODUCT OF BCL-2 INHIBITOR AND MDM2 INHIBITOR AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES | ASCENTAGE PHARMA SUZHOU CO LTD (CN) | 2021-09-29 | — | — | EP | disclosed |
| EP-3672595-B1 | COMBINATION PRODUCT OF BCL-2 INHIBITOR AND CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES | ASCENTAGE PHARMA SUZHOU CO LTD (CN) | 2021-07-21 | — | — | EP | disclosed |
| EP-3494115-B1 | N-(PHENYLSULFONYL)BENZAMIDE DERIVATIVES AS BCL-2 INHIBITORS | UNIV MICHIGAN REGENTS (US) | 2020-10-21 | — | — | EP | disclosed |
| EP-3569601-A2 | N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS | The Regents of The University of Michigan (US) | 2019-11-20 | — | — | EP | disclosed |